IL17A and chronic kidney disease: HS, as a chronic or relapsing disease involving the Th17/IL-17 axis, promotes fibrosis, loss of organ architecture, and function, which could lead to podocyte damage and renal dysfunction, such as acute kidney injury (AKI) or chronic kidney disease (CKD) 11.